AbstractThe mechanism of the first steps of the reaction catalyzed by HIV-1 protease was studied through molecular dynamics simulations. The potential energy surface in the active site was generated using the approximate valence bond method. The approximate valence bond (AVB) method was parameterized based on density functional calculations. The surrounding protein and explicit water environment was modeled with conventional, classical force field. The calculations were performed based on HIV-1 protease complexed with the MVT-101 inhibitor that was modified to a model substrate. The protonation state of the catalytic aspartates was determined theoretically. Possible reaction mechanisms involving the lytic water molecule are accounted for in...
The evolution of species is a complex phenomenon based on the optimization of a multidimensional fun...
The data described here supports the research article “Unraveling HIV Protease Flaps Dynamics by Con...
The efficiency of protease inhibiting drugs is hampered by the rapid emergence of protease variants....
AbstractThe mechanism of the first steps of the reaction catalyzed by HIV-1 protease was studied thr...
The binding mechanism of a peptide substrate (Thr-Ile-Met-Met-Gln-Arg, cleavage site p2-NC of the vi...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
ABSTRACT HIV-1 protease is most active un-der weakly acidic conditions (pH 3.5–6.5), when the cataly...
AbstractThe data described here supports the research article “Unraveling HIV Protease Flaps Dynamic...
The emergence of compensatory drug-resistant mutations in HIV-1 protease challenges the common view ...
The evolution of species is a complex phenomenon based on the optimization of a multidimensional fun...
The evolution of species is a complex phenomenon based on the optimization of a multidimensional fun...
The data described here supports the research article “Unraveling HIV Protease Flaps Dynamics by Con...
The efficiency of protease inhibiting drugs is hampered by the rapid emergence of protease variants....
AbstractThe mechanism of the first steps of the reaction catalyzed by HIV-1 protease was studied thr...
The binding mechanism of a peptide substrate (Thr-Ile-Met-Met-Gln-Arg, cleavage site p2-NC of the vi...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
HIV-1 protease is most active under weakly acidic conditions (pH 3.5-6.5), when the catalytic Asp25 ...
ABSTRACT HIV-1 protease is most active un-der weakly acidic conditions (pH 3.5–6.5), when the cataly...
AbstractThe data described here supports the research article “Unraveling HIV Protease Flaps Dynamic...
The emergence of compensatory drug-resistant mutations in HIV-1 protease challenges the common view ...
The evolution of species is a complex phenomenon based on the optimization of a multidimensional fun...
The evolution of species is a complex phenomenon based on the optimization of a multidimensional fun...
The data described here supports the research article “Unraveling HIV Protease Flaps Dynamics by Con...
The efficiency of protease inhibiting drugs is hampered by the rapid emergence of protease variants....